FDA inspection
Centrient Pharmaceuticals Spain S.A.: FDA inspection ending Sep 19, 2012
FDA inspection 803323 · No Action Indicated (NAI) · Santa Perpetua De Mogoda
Key facts
| Inspection ID | 803323 |
|---|---|
| Firm | Centrient Pharmaceuticals Spain S.A. |
| FEI number | 3003754230 |
| Address | C Ripolles, 2, Poligono Urvasa |
| City | Santa Perpetua De Mogoda |
| Country | Spain |
| Fiscal year | 2012 |
| Inspection end date | Sep 19, 2012 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data